Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy
Nat Med
.
2001 Sep;7(9):987-9.
doi: 10.1038/nm0901-987.
Author
R K Jain
1
Affiliation
1
Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts, USA. jain@steele.mgh.harvard.edu
PMID:
11533692
DOI:
10.1038/nm0901-987
No abstract available
Publication types
Review
MeSH terms
Blood Vessels / drug effects
Blood Vessels / pathology
Clinical Trials as Topic
Humans
Neoplasms / blood supply*
Neoplasms / therapy*
Neovascularization, Pathologic / drug therapy*